Showing results (41-50 of 75) with videos related to
Sort By:
Pageof 8
Journal of Medicinal Chemistry|March 5, 2004
Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexesC Andrew Boswell, Xiankai Sun, Weijun Niu, et al.American Journal of Preventive Medicine|November 16, 2010
An evaluation of health benefit modification in Taft-Hartley health and welfare funds: implications for encouraging tobacco-cessation coverageCaroline M Au-Yeung, Susan R Weisman, Deborah J Hennrikus, et al.American Journal of Surgery|November 1, 1994
A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancerK T Robbins, D Vicario, S Seagren, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cellsS Aebi, R Kröning, B Cenni, et al.American Journal of Preventive Medicine|October 20, 2012
Influencing Taft-Hartley Funds to provide tobacco cessation benefitsSusan R Weisman, Deborah Hennrikus, Kelvin Choi, et al.Dalton Transactions (Cambridge, England : 2003)|May 8, 2010
A new phosphonate pendant-armed cross-bridged tetraamine chelator accelerates copper(ii) binding for radiopharmaceutical applicationsDannon J Stigers, Riccardo Ferdani, Gary R Weisman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formationG Los, f A Blommaert, R Barton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancerG Los, K Benbatoul, D P Gately, et al.Dalton Transactions (Cambridge, England : 2003)|October 29, 2004
Inside or outside a ligand cleft? Synthetic, structural, and kinetic inertness studies of zinc, cadmium, and mercury complexes of cross-bridged cyclam and cyclenWeijun Niu, Edward H Wong, Gary R Weisman, et al.Journal of Medicinal Chemistry|January 11, 2002
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligandsXiankai Sun, Melinda Wuest, Gary R Weisman, et al.Pageof 8